Streamex (STEX)
Market Price (6/16/2026): $1.04 | Market Cap: $181.6 MilSector: Financials | Industry: Diversified Capital Markets
Streamex (STEX)
Market Price (6/16/2026): $1.04Market Cap: $181.6 MilSector: FinancialsIndustry: Diversified Capital Markets
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -17% Megatrend and thematic driversMegatrends include Digital Content & Streaming. Themes include Video Streaming, and Music Streaming. | Weak multi-year price returns2Y Excs Rtn is -124%, 3Y Excs Rtn is -159% | Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is 0 Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -104 Mil Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is null, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -65% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -292% High stock price volatilityVol 12M is 124% Key risksSTEX key risks include [1] significant financial distress and a high risk of bankruptcy, Show more. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -17% |
| Megatrend and thematic driversMegatrends include Digital Content & Streaming. Themes include Video Streaming, and Music Streaming. |
| Weak multi-year price returns2Y Excs Rtn is -124%, 3Y Excs Rtn is -159% |
| Very low revenueRev LTMTotal Revenue or Sales, Last Twelve Months is 0 |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -104 Mil |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is null, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -65% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -292% |
| High stock price volatilityVol 12M is 124% |
| Key risksSTEX key risks include [1] significant financial distress and a high risk of bankruptcy, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Streamex (STEX) stock has lost about 55% since 2/28/2026 because of the following key factors:
1. Lack of Revenue and Significant Losses.
Streamex reported $0 GAAP revenue for fiscal Q1 2026, consistent with the prior year, as its flagship product GLDY only began generating meaningful activity late in the quarter. The company posted a net loss of $48.6 million in fiscal Q1 2026 and experienced a substantial increase in operating expenses to $35.7 million, driven primarily by non-cash stock-based compensation.
2. Earnings Miss and Unmet Expectations.
The company's reported fiscal Q1 2026 earnings per share (EPS) of -$0.27 significantly missed analyst forecasts of -$0.05, representing a 440% miss. This financial underperformance, coupled with slower-than-anticipated conversion of initial institutional interest ($100 million) for GLDY into actual assets under management (AUM) by the end of fiscal Q1 2026, suggests a struggle to meet market expectations for its new tokenized commodity platform.
Show more
Stock Movement Drivers
Fundamental Drivers
The -54.5% change in STEX stock from 2/28/2026 to 6/15/2026 was primarily driven by a null change in the company's Total Revenues ($ Mil).| (LTM values as of) | 2282026 | 6152026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.22 | 1.01 | -54.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 0 | 0 | |
| P/S Multiple | 5,695.5 | ∞ | 9.2233720368547763E17% |
| Shares Outstanding (Mil) | 33 | 175 | -80.9% |
| Cumulative Contribution | 0.0% |
Market Drivers
2/28/2026 to 6/15/2026| Return | Correlation | |
|---|---|---|
| STEX | -54.5% | |
| Market (SPY) | 10.3% | 22.2% |
| Sector (XLF) | 4.7% | 5.8% |
Fundamental Drivers
The -77.6% change in STEX stock from 11/30/2025 to 6/15/2026 was primarily driven by a null change in the company's Total Revenues ($ Mil).| (LTM values as of) | 11302025 | 6152026 | Change |
|---|---|---|---|
| Stock Price ($) | 4.50 | 1.01 | -77.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 0 | 0 | |
| P/S Multiple | 11,544.9 | ∞ | 9.2233720368547763E17% |
| Shares Outstanding (Mil) | 33 | 175 | -80.9% |
| Cumulative Contribution | 0.0% |
Market Drivers
11/30/2025 to 6/15/2026| Return | Correlation | |
|---|---|---|
| STEX | -77.6% | |
| Market (SPY) | 11.1% | 22.6% |
| Sector (XLF) | 1.3% | 11.3% |
Fundamental Drivers
nullnull
Market Drivers
5/31/2025 to 6/15/2026| Return | Correlation | |
|---|---|---|
| STEX | ||
| Market (SPY) | 29.5% | 25.3% |
| Sector (XLF) | 6.7% | 17.0% |
Fundamental Drivers
nullnull
Market Drivers
5/31/2023 to 6/15/2026| Return | Correlation | |
|---|---|---|
| STEX | ||
| Market (SPY) | 87.7% | 25.3% |
| Sector (XLF) | 77.0% | 17.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| STEX Return | - | - | - | - | -49% | -68% | -84% |
| Peers Return | 58% | 0% | 23% | 44% | -4% | 10% | 197% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 9% | 98% |
Monthly Win Rates [3] | |||||||
| STEX Win Rate | - | - | - | - | 0% | 33% | |
| Peers Win Rate | 79% | 54% | 62% | 71% | 45% | 63% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| STEX Max Drawdown | - | - | - | - | - | -80% | |
| Peers Max Drawdown | -14% | -36% | -23% | -22% | -28% | -32% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: BGDE, LCLN, LPLA, TW, CRCL.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 6/15/2026 (YTD)
How Low Can It Go
STEX has limited trading history. Below is the Financials sector ETF (XLF) in its place.
| Event | XLF | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -15.5% | -18.8% |
| % Gain to Breakeven | 18.4% | 23.1% |
| Time to Breakeven | 80 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -10.7% | -9.5% |
| % Gain to Breakeven | 12.0% | 10.5% |
| Time to Breakeven | 26 days | 24 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -16.1% | -6.7% |
| % Gain to Breakeven | 19.1% | 7.1% |
| Time to Breakeven | 270 days | 31 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -22.3% | -24.5% |
| % Gain to Breakeven | 28.6% | 32.4% |
| Time to Breakeven | 467 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -42.8% | -33.7% |
| % Gain to Breakeven | 74.8% | 50.9% |
| Time to Breakeven | 289 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -19.7% | -19.2% |
| % Gain to Breakeven | 24.5% | 23.8% |
| Time to Breakeven | 123 days | 105 days |
In The Past
State Street Financial Select Sector SPDR ETF's stock fell -15.5% during the 2025 US Tariff Shock. Such a loss loss requires a 18.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
STEX has limited trading history. Below is the Financials sector ETF (XLF) in its place.
| Event | XLF | S&P 500 |
|---|---|---|
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -22.3% | -24.5% |
| % Gain to Breakeven | 28.6% | 32.4% |
| Time to Breakeven | 467 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -42.8% | -33.7% |
| % Gain to Breakeven | 74.8% | 50.9% |
| Time to Breakeven | 289 days | 140 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -21.4% | -12.2% |
| % Gain to Breakeven | 27.3% | 13.9% |
| Time to Breakeven | 272 days | 62 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -26.1% | -17.9% |
| % Gain to Breakeven | 35.3% | 21.8% |
| Time to Breakeven | 162 days | 123 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -78.3% | -53.4% |
| % Gain to Breakeven | 359.8% | 114.4% |
| Time to Breakeven | 2329 days | 1085 days |
In The Past
State Street Financial Select Sector SPDR ETF's stock fell -15.5% during the 2025 US Tariff Shock. Such a loss loss requires a 18.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Streamex (STEX)
AI Analysis | Feedback
Here are 1-2 brief analogies for Streamex (STEX), based on the provided company description:
- A specialized Medtronic or Boston Scientific for enhancing the clarity of heart electrical signals in electrophysiology.
- The Dolby for cardiac electrophysiology, providing clearer, real-time signals for heart rhythm treatments.
AI Analysis | Feedback
nullAI Analysis | Feedback
nullAI Analysis | Feedback
nullAI Analysis | Feedback
Henry McPhie, Chief Executive Officer
Henry McPhie is the Co-Founder and Chief Executive Officer of Streamex, leading the company's mission to revolutionize real-world asset tokenization and bring commodities on-chain through cutting-edge blockchain solutions. A seasoned entrepreneur and visionary technologist, he has a strong track record of building innovative companies at the intersection of blockchain and finance. Prior to founding Streamex, Mr. McPhie founded Lynx Web3 Solutions, a blockchain incubation and software development firm. He also founded FatCats Capital, a Solana-based NFT project that quickly became the third largest in the world at the time of its launch, cultivating a global community of over 100,000 members. He holds a degree in Mining Engineering from McGill University.
Morgan Lekstrom, Executive Chairman
Morgan Lekstrom is the Co-Founder and Executive Chairman of Streamex. He is a seasoned mining executive and corporate strategist with over 17 years of experience building and transforming resource companies, bringing deep expertise in capital markets, strategic M&A, and commodities. Mr. Lekstrom previously served as CEO of NexMetals Mining Corp., where he developed critical metals projects in Botswana with US$150 million backing from the Export-Import Bank of the United States. As President of NexGold Mining, he orchestrated strategic transformations through mergers. His global experience includes senior technical roles at Freeport McMoran's Grasberg mine and Rio Tinto's Oyu Tolgoi project. He co-founded Streamex with Henry McPhie approximately 3.5 years ago and is one of the largest shareholders.
Ferdinand Groenewald, Chief Financial Officer
Ferdinand Groenewald is the Chief Financial Officer of Streamex Corp. He is a certified public accountant with significant experience in finance and accounting. Mr. Groenewald currently serves as Vice President, Finance at Alaunos Therapeutics, Inc. His previous roles include serving as an Independent Outside Director at SYLA Technologies Co., Ltd., HeartCore Enterprises, Inc., and Sushi Ginza Onodera, Inc. He also held positions as an Accountant at Wrinkle, Gardner & Co. PC, a Senior Staff Accountant at Financial Consulting Strategies LLC, a Controller, VP-Finance & Accounting Officer, and Chief Financial Officer at Sadot Group, Inc., and Chief Accounting Officer & VP-Finance at Muscle Maker Development LLC. Mr. Groenewald obtained an undergraduate degree from the University of South Africa.
Mitchell Williams, CFA, Chief Investment Officer
Mitchell Williams, CFA, is the Chief Investment Officer of Streamex, a position he has held since 2025. He brings over 20 years of experience from Wall Street, consistently driving performance through strategic insight, innovation, and disciplined investment management. Mr. Williams began his investment career at Credit Suisse on the Internet Financial Services team during the Web 1.0 era. He went on to hold senior executive roles at OppenheimerFunds and Wafra Inc., where he managed multi-billion dollar global and domestic equity portfolios and led high-performing investment teams. At Wafra, he grew assets under management more than threefold and achieved top-quartile performance. At OppenheimerFunds, he was a highly ranked equity analyst and sole portfolio manager for one of the firm's flagship funds. Prior to his current role, he served as a Strategic Advisor on Capital Markets for Streamex. He earned an MBA from NYU Stern School of Business (where he was a Stern Fellowship recipient) and a BA from the University of Florida.
Russell Starr, Head of Capital Markets
Russell Starr was appointed Head of Capital Markets for Streamex. He brings over 25 years of capital markets experience, spanning US Capital Markets, emerging technology, tokenized finance, and Web3 infrastructure.
AI Analysis | Feedback
- Regulatory Approval and Compliance Risk: As a medical device company, Streamex (BioSig Technologies, Inc.) faces significant and ongoing risks associated with obtaining and maintaining regulatory approvals (e.g., FDA clearance) for its PURE EP system and any future product enhancements or new therapies. Failure to secure or sustain these approvals, or to comply with stringent medical device regulations, could prevent the company from marketing its products or lead to product recalls and significant penalties.
- Market Adoption and Commercialization Risk: The success of Streamex's PURE EP system relies heavily on its adoption by electrophysiologists and medical institutions. There is a risk that healthcare providers may not widely adopt the system, either due to a lack of perceived clinical benefit over existing solutions, high acquisition costs, challenges in integration into current workflows, or insufficient market education and sales efforts. Slow or limited market penetration would negatively impact revenue and growth.
- Competition and Technological Obsolescence Risk: The medical device market, particularly in specialized fields like electrophysiology, is highly competitive and subject to rapid technological advancements. Streamex faces risks from competitors developing superior, more cost-effective, or alternative technologies that could render the PURE EP system less competitive or even obsolete. The need to continually innovate and differentiate its products, as indicated by collaborations for AI/machine learning and novel therapies, highlights this ongoing challenge.
AI Analysis | Feedback
null
AI Analysis | Feedback
Streamex (STEX), formerly known as BioSig Technologies, Inc., has undergone a significant corporate rebranding and shifted its strategic focus from medical devices to real-world asset (RWA) tokenization and gold-related financial infrastructure. The addressable markets for Streamex's main products and services are as follows:Real-World Asset (RWA) Tokenization Market
The market for tokenized real-world assets is experiencing rapid growth globally. As of early 2026, the market size for tokenized RWAs has reached over $25 billion, a nearly fourfold increase from approximately $6.4 billion a year prior. Other estimates place the current RWA market at roughly $19–$22 billion in January 2026 and $24 billion in June 2025. Looking ahead, the projections for the RWA tokenization market are substantial:- McKinsey estimated that tokenized financial assets could reach approximately $2 trillion by 2030, excluding cryptocurrencies and stablecoins.
- Citi GPS forecasts growth to almost $4 trillion by 2030, particularly in private markets.
- Roland Berger's 2023 report projects the market to be at least $10.9 trillion by 2030.
- Boston Consulting Group (BCG) and ADDX estimate a market size of $16.1 trillion by 2030.
- Ark Invest suggests tokenized assets could grow to about $11 trillion by 2030.
- Other experts predict that $16-30 trillion of real-world assets will be tokenized by 2030.
- A broader market report estimates the global asset tokenization market was valued at USD 2.06 trillion in 2024 and is expected to reach USD 41.94 trillion by 2032, growing at a CAGR of 45.83% over 2025-2032.
- The U.S. asset tokenization market specifically was valued at USD 0.57 trillion in 2024 and is expected to reach USD 11.55 trillion by 2032.
- Standard Chartered projects the market to reach $30.1 trillion by 2034.
Gold Tokenization Market
The tokenized gold market has shown significant momentum. Its total market capitalization surpassed $6 billion as of February 2026, marking a gain of approximately $2 billion year-to-date. In Q4 2025, the tokenized gold market cap added nearly $2.8 billion in net value, moving from $1.6 billion to $4.4 billion. Forecasts for tokenized gold indicate continued expansion:- Wintermute anticipates the tokenized gold market to reach $15 billion in 2026 due to accelerated institutional adoption.
- Analysts expect tokenized gold to become a foundational layer of RWA tokenization, a sector projected to exceed $16 trillion by 2030.
On-Chain Commodity Markets
The broader tokenized commodities sector, which includes gold, has also seen substantial growth. The cumulative market capitalization of the tokenized commodities sector increased by 10% over the past month to $7.69 billion as of March 2026. For the global commodity services market (a broader category that includes traditional commodity services in addition to on-chain offerings), the size was estimated at USD 4885.29 billion in 2026 and is projected to reach USD 8045.73 billion by 2035. Another report estimated the global commodity services market at USD 3.56 billion in 2024, predicted to increase to approximately USD 8.16 billion by 2034.AI Analysis | Feedback
Streamex Corp. (STEX), formerly BioSig Technologies, Inc., underwent a significant strategic transformation in September 2025, pivoting its business model from medical devices to real-world asset (RWA) tokenization. The company now focuses on building institutional-grade infrastructure for gold tokenization and broader on-chain commodity markets. Its offerings include gold-backed financial instruments and regulated, yield-bearing digital assets like its GLDY token. Based on this strategic shift and current business focus, the following are expected drivers of future revenue growth for Streamex over the next 2-3 years:-
Growth in Real-World Asset (RWA) Tokenization Market Adoption: As a company primarily focused on RWA tokenization, particularly with gold-backed assets, Streamex's revenue growth is intrinsically linked to the increasing adoption and institutional acceptance of tokenized real-world assets. The expansion of this nascent market, driven by perceived benefits like increased liquidity, transparency, and fractional ownership, would directly translate into higher demand for Streamex's tokenization and trading infrastructure services.
-
Expansion of Tokenized Commodity Offerings: While gold tokenization is a primary focus, Streamex's vertically integrated platform is designed to bring a broader range of commodities on-chain. Expanding its offerings beyond gold to include other precious metals or commodities would open new revenue streams and attract a wider array of institutional and retail investors seeking diversified tokenized asset exposure.
-
Strategic Partnerships and Institutional Integrations: Collaborations with asset managers, financial institutions, and other key players in the digital asset ecosystem are crucial for Streamex's growth. The company has explicitly stated its aim to integrate tokenized gold into regulated investment products and leverage strategic partnerships. For example, Streamex recently announced a letter of intent with Simplify Asset Management to explore strategic partnerships to drive ETF innovation through the integration of tokenized gold yield assets and tokenization of existing ETFs. Such partnerships can significantly increase the reach and utility of Streamex's tokenized products, driving transaction volumes and platform usage.
-
Development and Adoption of Yield-Bearing Digital Assets: Streamex is developing and offering yield-bearing gold products. The success and widespread adoption of these innovative financial products, such as its GLDY token backed by physical gold, could be a significant revenue driver. Attracting investors with the potential for yield on traditionally non-yielding assets like gold would differentiate Streamex and expand its customer base.
AI Analysis | Feedback
Here is a summary of Streamex's capital allocation decisions over the last 3-5 years:Share Issuance
- In August 2025, Streamex completed a public offering, raising approximately $15 million in gross proceeds from the sale of 3,852,149 shares of common stock at $3.90 per share. The company planned to use these proceeds to purchase gold bullion, for general corporate purposes, and for working capital.
- In March 2025, the company sold 758,514 shares of common stock and issued warrants to certain accredited investors, generating an aggregate of $818,998.
- In September 2025, shareholders approved an increase in the number of authorized shares of common stock from 200 million to 500 million.
Inbound Investments
- In July 2025, the company entered into definitive agreements with an institutional investor for up to $1.1 billion in growth financing. This included an offering of $75 million in senior secured convertible debentures and an equity line of credit.
Outbound Investments
- Around June 2025, BioSig Technologies, Inc. acquired Streamex Exchange Corporation, incurring total acquisition-related costs of approximately $7.1 million, which included the issuance of common stock to third-party consultants. This acquisition marked a strategic shift towards real-world asset tokenization.
- The company has acquired an equity interest in a royalty and streaming company to expand its exposure to gold and silver royalty and streaming assets.
Capital Expenditures
- Amortization expenses for intangible assets increased significantly from $10 for the six months ended June 30, 2024, to $545 for the six months ended June 30, 2025, primarily due to intangible assets acquired in connection with the Streamex acquisition (e.g., trade name, developed technology, legal and compliance framework).
- Proceeds from an August 2025 public offering, approximately $15 million, were intended to be used for the purchase of gold bullion, aligning with the company's investment policy for its new gold tokenization business model.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Can Streamex Stock Recover If Markets Fall? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 53.34 |
| Mkt Cap | 21.0 |
| Rev LTM | 2,161 |
| Op Inc LTM | -25 |
| FCF LTM | -24 |
| FCF 3Y Avg | -10 |
| CFO LTM | -20 |
| CFO 3Y Avg | 284 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 18.3% |
| Rev Chg 3Y Avg | 21.5% |
| Rev Chg Q | 20.6% |
| QoQ Delta Rev Chg LTM | 4.7% |
| Op Inc Chg LTM | -5.8% |
| Op Inc Chg 3Y Avg | 20.1% |
| Op Mgn LTM | 2.0% |
| Op Mgn 3Y Avg | 5.0% |
| QoQ Delta Op Mgn LTM | -1.0% |
| CFO/Rev LTM | 7.6% |
| CFO/Rev 3Y Avg | 8.1% |
| FCF/Rev LTM | 4.8% |
| FCF/Rev 3Y Avg | 4.7% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 21.0 |
| P/S | 7.1 |
| P/Op Inc | 6.4 |
| P/EBIT | 7.1 |
| P/E | 12.3 |
| P/CFO | 4.4 |
| Total Yield | 1.9% |
| Dividend Yield | 0.2% |
| FCF Yield 3Y Avg | 1.3% |
| D/E | 0.0 |
| Net D/E | -0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 1.1% |
| 3M Rtn | -7.1% |
| 6M Rtn | 0.7% |
| 12M Rtn | -23.2% |
| 3Y Rtn | 23.3% |
| 1M Excs Rtn | 0.6% |
| 3M Excs Rtn | -19.9% |
| 6M Excs Rtn | -15.2% |
| 12M Excs Rtn | -46.8% |
| 3Y Excs Rtn | -51.5% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Single segment | 0 | 0 | |||
| BioSig | 0 | 0 | 0 | ||
| BioSig AI Sciences | 0 | ||||
| ViralClear | 0 | ||||
| Total | 0 | 0 | 0 | 0 | 0 |
| $ Mil | 2023 | 2022 | 2020 |
|---|---|---|---|
| ViralClear | 1 | -1 | -28 |
| BioSig AI Sciences | -1 | ||
| BioSig | -29 | -27 | -31 |
| NeuroClear | -0 | -0 | |
| Total | -29 | -27 | -59 |
| $ Mil | 2025 | 2024 | 2021 | 2020 |
|---|---|---|---|---|
| Single segment | -463 | -10 | ||
| BioSig | -30 | -31 | ||
| NeuroClear | -0 | -0 | ||
| ViralClear | -3 | -28 | ||
| Total | -463 | -10 | -33 | -59 |
| $ Mil | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| BioSig AI Sciences | 1 | ||||
| BioSig | 0 | 4 | 14 | 25 | |
| ViralClear | 0 | 0 | 2 | 6 | |
| NeuroClear | 0 | ||||
| Single segment | 14 | ||||
| Total | 2 | 4 | 16 | 30 | 14 |
Returns Analyses
Earnings Returns History
Updated 6/2/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/14/2026 | 10-Q |
| 12/31/2025 | 03/31/2026 | 10-K |
| 09/30/2025 | 11/14/2025 | 10-Q |
| 06/30/2025 | 08/15/2025 | 10-Q |
| 03/31/2025 | 05/19/2025 | 10-Q |
| 12/31/2024 | 04/15/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/14/2024 | 10-Q |
| 03/31/2024 | 05/20/2024 | 10-Q |
| 12/31/2023 | 04/16/2024 | 10-K |
| 09/30/2023 | 11/14/2023 | 10-Q |
| 06/30/2023 | 08/14/2023 | 10-Q |
| 03/31/2023 | 05/15/2023 | 10-Q |
| 12/31/2022 | 03/31/2023 | 10-K |
| 09/30/2022 | 11/14/2022 | 10-Q |
| 06/30/2022 | 08/15/2022 | 10-Q |
Insider Activity
Updated 6/15/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Lekstrom, Morgan Lee | Interim Executive Chairman | All Mine Consulting LTD. | Buy | 6152026 | 0.99 | 50,000 | 49,750 | 357,702 | Form |
| 2 | Williams, Mitchell Young | Chief Investment Officer | Direct | Sell | 6022026 | 1.05 | 23,810 | 24,915 | 3,153,680 | Form |
| 3 | Marciano, Anthony Mark | Direct | Buy | 5222026 | 1.13 | 17,745 | 20,052 | 133,052 | Form | |
| 4 | Lekstrom, Morgan Lee | Interim Executive Chairman | All Mine Consulting LTD. | Buy | 5212026 | 1.04 | 147,000 | 153,099 | 280,682 | Form |
| 5 | Williams, Mitchell Young | Chief Investment Officer | Direct | Sell | 5042026 | 0.79 | 263,863 | 209,718 | 2,414,323 | Form |
Industry Resources
| Financials Resources |
| Federal Reserve Economic Data |
| Federal Reserve |
| FDIC Data |
| American Banker |
| The Banker |
| Banking Technology |
| Diversified Capital Markets Resources |
| International Financing Review (IFR) |
| Financial News |
| Global Capital |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.